This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's beliefs and assumptions in light of information currently available to management. Accordingly, the
Company's actual results may differ materially from those expressed or implied in such forward-looking statements due to
known or unknown risks and uncertainties that exist in the Company's operations and business environment, including, among other factors, those described in documents filed by the Company with the Securities and Exchange Commission, specifically its Form 10-Ks and 10-Qs. The Company does not assume any obligation to update, amend or clarify such statements to reflect new events, information or circumstances after the date of this presentation.
During the course of this presentation, certain non-GAAP financial information will be presented.
A reconciliation of those numbers to GAAP financial measures is available on the company's website at www.aptar.comon the Investor's page (click on Events & Presentations / Presentations).
2
Overview
3
Aptar Snapshot
"We reimagine packaging solutions to improve everyday life for people everywhere."
THE LEADER IN CONSUMER DISPENSING AND DRUG DELIVERY
75-year history of innovation
Providing brand differentiation and consumer / patient convenience
Consistent long-term focus, stability
and financial results
SERVING BEST KNOWN GLOBAL & LOCAL BRANDS
RESEARCH AND IP-DRIVEN
R & D
3%
Approximately
Of Annual Revenue 1,250
Patent Families
ATTRACTIVE END MARKETS
$2.9 bil*
*2019 Annual Revenue
SALES BY REGION
DIVERSIFIED PORTFOLIO
32%
55%
6%
7%
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
AptarGroup Inc. published this content on 22 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 September 2020 20:59:01 UTC
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
